Orthofix appoints Julie Dewey, Chief Human Resources Officer, as Communications Officer

Julie Dewey, Director of Investor Relations and Communications at Orthofix (Photo courtesy of Orthofix)


(Nasdaq: OFIX)

announced today that it has named Julie Dewey as its new director of investor relations and communications.

Along with the latest appointment news, Orthofix also announced that Max Reinhardt has officially begun his role as president of the company’s global spine division. Both Dewey and Reinhardt will be members of the Orthofix leadership team.

Dewey previously held leadership positions at numerous global publicly traded medical device companies. Most recently, she was director of communications and investor relations at Treace Medical Concepts.

“We are thrilled to welcome Julie to the company,” Orthofix president and CEO Massimo Calafiore said in a press release. “She is deeply respected in the industry and brings with her a wealth of knowledge of our markets, technologies and growth strategies. Her appointment not only strengthens our leadership team, but also further solidifies our focus on expanding our reach with investors and analysts as we continue to increase profitability and growth for our shareholders.”

Dewey has held numerous positions of varying responsibility in the medical device industry. Prior to Treace, she was Director of Corporate Communications and Chief IR at Nevro and Senior Vice President and Chief Communications Officer at Wright Medical, which was acquired by Stryker in 2020.

“I am excited to join Orthofix in this new leadership role at such a transformative time in the company’s growth trajectory,” said Dewey. “I look forward to working with Massimo and the rest of the Orthofix team to execute on the company’s growth strategy and deliver a best-in-class experience to the investment community and key stakeholders.”

Reinhardt’s nomination was previously announced on May 23. Most recently, he was global president of DePuy Synthes Spine. Reinhardt will be responsible for leading SeaSpine, Orthofix’s global spine care and biologics business, which was formed through a massive merger last year.

Dewey’s appointment is the latest significant step in leadership at the Lewisville, Texas-based company. Last fall, the company terminated the contracts of three directors with cause. Following the investigation, Orthofix severed ties with CEO Keith Valentine, CFO John Bostjancic and chief legal officer Patrick Keran.

The company then chose former LimaCorporate CEO Massimo Calafiore as its next CEO in November. In January, Julie Andrews took over as chief financial officer, and in April, Andres Cedron was named chief legal officer.